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To review child sexual abuse cases and their management 
presenting to Queen Elizabeth Central Hospital (QECH), 
Blantyre, since the introduction of  an HIV post-exposure 
prophylaxis (PEP) programme. .
Methods
Demographic and medical data was collected from all 
children presenting to Queen Elizabeth Central Hospital, 
Blantyre, Malawi between January 2005 and February 2007 
with alleged child sexual abuse (CSA).
Results
Between January 2005 and February 2007, 217 children 
presented with alleged CSA. This is an average of  3 more per 
month since the previous year. The results of  the physical 
examination in 60% (130/217) of  the cases showed signs 
of  trauma. 63% (137/217) of  the cases presented within 72 
hours of  defilement. Overall in 42% (92/217) of  children 
a one month course of  HIV PEP was indicated and given. 
In 58% (125/217) HIV PEP was not indicated in view of  
normal examination, presentation too late (>72 hrs after 
abuse), multiple abuse episodes in the last 6 months, HIV test 
positive or HIV test refused. In 66% (144/217) of  assessed 
children antibiotic treatment was given for the prevention 
and/ or treatment of  sexually transmitted infections (STIs).
Conclusions
The introduction of  an HIV PEP programme for victims 
of  CSA has lead to increased numbers presenting and being 
treated. In conclusion it is likely that a significant number of  
children have been prevented from acquiring HIV and other 
STIs following CSA. The key area where our service needs 
to be improved is in establishing documented follow up of  
all cases to monitor medication compliance, side effects and 
rates of  HIV seroconversion following CSA.
Introduction
In January 2004 a programme to provide HIV post-exposure 
prophylaxis (PEP) to eligible children suffering from child 
sexual abuse (CSA) was established in Queen Elizabeth 
Central Hospital, Blantyre, Malawi1. This was in view of  
the high HIV seroprevalance in Malawi, the risk of  children 
contracting HIV following CSA and the availability of  
antiretroviral therapy (ARVs).
The presumed mechanism of  action of  HIV PEP is that 
shortly after exposure to HIV the viral load is small enough 
to be controlled by the body’s immune system, and ARVs 
at this time may end viral replication2. For this reason HIV 
PEP is recommended in many circumstances, including 
risk reduction of  mother to child transmission of  HIV3 
and occupational exposure to HIV4. United Kingdom and 
American guidelines recommend HIV PEP for children after 
sexual exposure depending on the risk of  seroconversion5,6,7,8. 
HIV PEP is recommended as part of  post-rape care in high 
prevalence areas such as South Africa9. 
Risk of  HIV transmission is calculated as the likelihood 
that the source is HIV infected multiplied by the type of  
exposure5. With the high HIV seroprevalance in Malawi, 
estimated prevalence in adults (15- 49 yrs) in 2007 was 11.9%10, 
there is a substantial risk that a perpetrator is HIV infected. 
The risk of  exposure is especially high in a sexually abused 
premenarchial girl when there has been an associated trauma. 
This is due to increased HIV transmission in the presence of  
cervical ectopy and an immature thin premenarchial vaginal 
epithelium8,11. A service which provides HIV PEP was 
deemed essential in the central teaching hospital in Blantyre, 
Malawi and was set up in January 2004. During the first year, 
64 children presented with alleged child sexual abuse1. Here 
we present the numbers presenting between January 2005 
and February 2007.
Methods
Queen Elizabeth Central Hospital (QECH) is a tertiary 
level referral hospital in Blantyre, Southern Malawi. In 
January 2002 a standardised clinical assessment12 form 
was introduced to assess children presenting as victims of  
CSA. Demographic data is collected, details and timings 
of  alleged assault are recorded. A full medical history is 
taken and systemic and anogenital examination performed 
and recorded by a specialist paediatric doctor (registrar or 
consultant) or specialist paediatric clinical officer, with nurse 
presence, in a designated private room for the purpose, 
containing necessary investigations and medication in a 
locked cupboard.
From January 2004 a written protocol was introduced to 
determine eligibility for HIV PEP13. Children with a history 
of  alleged sexual abuse are considered eligible for PEP if  
they are seen less than 72 hours after the abuse, have not 
been previously assaulted in the last 6 months, there  are 
signs of  trauma (vaginal or anal) on medical examination (for 
specific signs see reference 24), they are HIV sero-negative 
on testing on the day of  presentation (test undertaken after 
pre-counselling), and the child and guardian agree to comply 
with treatment. 
If  the child is eligible for PEP they were given a 30 day 
course of  zidovudine and lamivudine, dosed according 
to body weight. All children are offered follow up in the 
general paediatric clinic or paediatric A&E one month from 
presentation. If  the child is found to be HIV positive on 
testing they are referred to the paediatric antiretroviral clinic. 
If  the child is not eligible for PEP they are offered an HIV 
test if  indicated and a repeat test in 3 months.
In addition to HIV PEP, where there is a history of  alleged 
CSA children are offered antibiotics to help prevent other 
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sexually transmitted infections (STIs). If  there is evidence 
of  trauma, tetanus toxoid and need for surgical intervention 
is considered. Pregnancy testing is offered to children post-
menarche. If  it is felt that the child is vulnerable to repeated 
abuse at home they are admitted and social services are asked 
to investigate the home circumstances.
Data was collected retrospectively in March 2007 from the 
completed standardised clinical assessment forms. Clinical 
assessment forms are stored in a locked office only accessible 
to immediate service providers. Data collected from forms 
was anonymised.
Results
Between January 2005 and February 2007, 217 children 
presented with alleged CSA. This is an average of  8.3 (range 
1-18) children/ month. The overall trend of  number of  cases 
is increasing (see figure 1), with an average of  6.5/month 
presenting in the 13 months from January 2005 to January 
2006 an average of  10.2/month presenting from February 
2006 to February 2007 (p=0.035) (Mann-Whitney test 
comparing monthly attendance between two time frames). 
In 2004 64 children (average 5.3/month) presented with 
alleged CSA1. There have been on average an extra 3 cases/
month since 2004. 
Fifty two percent (113/217) of  children were in the age 
group 5-10 years old, 29% (62/217) were under 5 years old 
and 19% (42/217) were 11-16 years old. The median age was 
7 years old, ranging from 14 months to 16 years.
Almost all (95%, 207/217) of  the victims were girls and 5 % 
(10/217) male. Of  the female children 96% (198/207) had 
not yet started menses.
A single alleged defilement episode was reported in 65% 
(142/217) of  cases. 25% (54/217) reported multiple 
episodes. In 10% (21/217) of  cases the child did not report 
defilement, but it was suspected on other grounds. 
Time from the last alleged incident was less than 72 hours 
in 63% (137/217) of  cases. In 29% (62/217) of  cases it was 
more than 72 hours. Timing was not given in 8% (18/217) 
of  cases.
The alleged perpetrator was known to the child in 65% 
(141/217) cases, and unknown in 35% (76/217) cases. Where 
the alleged perpetrator was known, in 16% cases (22/141) 
they were a family member.
Vaginal rape was alleged in 81% (175/217) of  cases, anal rape 
in 6% (14/217) of  cases, and other types of  sexual assault, 
or details were not provided by the child in 13% (28/217) 
of  cases. 
The results of  the physical examination in 60% (130/217) 
of  cases showed signs of  trauma. In the remaining 40% 
(87/217) of  cases the examination was normal.
In no cases was the HIV status of  the alleged perpetrator 
known.
Of  those offered an HIV spot test 92.8% (142/153) were 
non-reactive, 4.6% (7/153) were reactive and 2.6% (4/153) 
refused testing. Those who were found to be HIV positive 
were referred to the paediatric ARV clinic.
Overall in 42% (92/217) of  children HIV PEP was indicated 
and given, in 58% (125/217) HIV PEP was not indicated 
as examination was normal, presentation too late (>72 hrs), 
multiple episodes of  abuse had occurred over a period of  
time, the child’s HIV test was positive or an HIV test was 
refused.
In 66% (144/217) of  assessed children antibiotic treatment 
was given for the prevention/ treatment of  STIs. 
Discussion
Changes since implementation of  HIV PEP 
service for CSA in QECH
We can see that since the establishment of  this service the 
number of  children brought for assessment and management 
have increased. This could be because the incidence of  CSA 
is rising, or because more children are attending now that 
HIV PEP is available. CSA is reported to be increasing in 
South Africa14, but decreasing in USA15. In other areas in 
Africa when similar services were established, unexpectedly 
high numbers presented16,17. It is likely that we are seeing only 
a small proportion of  the total numbers of  cases.
It is important that we rise to the challenge to provide more 
comprehensive care to more victims of  CSA. This includes 
not only medical interventions of  HIV PEP, and prevention 











































































































Graph 1: Number of  children presenting to Queen Elizabeth Central Hospital, Blantyre, with alleged child sexual abuse per month between 
January 2005 and February 2007
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to offer follow up, counselling and support.
Our audit found a high number of  children with positive 
physical examination findings. This differs greatly from 
countries such as the USA, where positive physical examination 
findings are only found in 4% of  cases18. Possible reasons for 
this are that in Malawi families may not present unless there 
are physical signs of  injury. The QECH is a tertiary referral 
hospital and may only be referred the most severe cases. Or 
it may be because the majority of  referrals come from the 
police who may only refer severe cases. 
Training implications
With the increase in cases of  child sexual abuse there is the 
need for more staff  to be trained in the medical assessment 
and examination of  these children. In our hospital child 
sexual abuse assessments are carried out by paediatric 
specialist doctors or clinical officers. To our knowledge, 
QECH is the only hospital in Malawi that provides this 
service in a formalised manner. However CSA happens in 
all communities. The establishment of  training courses for 
paediatric medical staff  in district hospitals would enable more 
children to receive timely HIV PEP in eligible circumstances. 
The importance of  proper and correct physical examination 
and documentation cannot be overemphasised as this has 
implications not only on the child’s treatment, but also legal 
implications if  a perpetrator is brought before the court. 
Both training and experience are necessary to be able to carry 
out such examinations. Both variants of  normal genitalia, 
and subtle signs of  abuse, must be interpreted correctly. 
Examination must be done in a standardised manner by a 
trained clinician. Findings need to be accurately documented 
in a clear format that is understandable to clinicians, police 
and public. A national standardised clinical assessment form 
such as the one used in QECH12 would be helpful towards 
developing standardised assessments.
Importance of  one stop service
A key learning point for our department in setting up 
this service was the importance of  offering assessment, 
examination, pre HIV test counselling, HIV testing and HIV 
PEP administration, if  indicated, at the same point of  care 
with 24 hour accessibility. This enables the maximum number 
of  children to benefit from HIV PEP where indicated, 
rather than some missing out if  unable to complete the 
process when sent to different departments of  the hospital 
for some of  the treatments or tests. This has caused a high 
drop out rate in HIV PEP programmes elsewhere17. Having 
a one stop service also minimises time delay in receiving 
HIV PEP, in a situation that is time critical. Furthermore if  
indicated, the full 30 day course of  treatment is provided on 
the day of  assessment. In KwaZulu-Natal only the first week 
of  treatment was dispensed, requiring patients to return at 
one week and regularly after that to be able to complete the 
full treatment course16. In the recent Refentse intervention 
study in rural South Africa provision of  the full course of  
treatment on the day of  assessment is strongly recommended 
to enhance adherance25.
Problems with our service: time of  presentation
HIV PEP is most effective when taken as soon as possible 
after exposure, preferably within the hour6,19. The longer 
time from exposure, the less likely PEP is to be effective, so 
that after 72 hours post exposure it is rarely indicated7,20. 
In our sample 29% (62/217) of  children presented more 
than 72 hours after the event, thus excluding them being 
eligible for HIV PEP. This result is similar to findings in 
South Africa16.
In Malawi there are inevitable delays in presentation. Firstly 
it is likely that the many of  the victims do not present at 
all, or have a delayed presentation in view of  stigma, lack 
of  family support, and transport difficulties1. Of  those that 
presented the vast majority were referred from the police, as 
the legal notification is deemed more important than medical 
assessment. By seeing the police first this creates a delay in 
receiving HIV PEP. However it does create a certain pathway 
of  referral.
This could be improved by education of  the public of  the 
benefit of  coming for medical assessment following CSA, 
and of  the importance of  coming as soon as possible after 
the event. 
Problems with our service: follow up
A key problem with our service is providing long term 
follow up. All children who received PEP were given follow 
up appointments for one month time to monitor for side 
effects, compliance and repeat HIV testing. Follow up was 
offered either at the paediatric A&E, or at paediatric general 
outpatients clinic. As the children were seen by different 
clinicians and the follow up consultations recorded in the 
child’s health passport, we were unable to collect data on 
numbers that returned for follow up. This means we have no 
data available on compliance with the 30 day course of  HIV 
PEP, or the results of  follow up HIV tests. Therefore we do 
not know the efficacy of  our service. In previous studies in 
Africa adherence rates to HIV PEP in CSA has been poor 
in Zambia21, Kenya17 and Malawi1. Mean adherence rates in 
these studies was 55% (range: 44.8- 64.7%)16. In KwaZulu-
Natal, South Africa adherence rates in CSA survivors were 
35.4% who returned for the full 28 day course, and only 
3.5% who returned for both 3 and 6 month follow-up16. This 
could be due to factors such as lack of  understanding of  the 
need for follow up, difficulties in transportation, adverse drug 
reactions, poor social support and traumatic associations 
of  the assault 1,16,17. In addition to reduced efficacy, poor 
adherence to medication may theoretically lead to acquisition 
of  a drug resistant virus, should the individual become HIV 
infected5.
Without follow up, side effects of  medication cannot be 
monitored. This is necessary to know to help determine the 
risk benefit ratio of  providing treatment. In Kenya there were 
few reported side effects in children, with no haematological 
or hepatotoxicity on the same PEP drug regime as used in 
Malawi17.
Lack of  follow up for those not eligible for HIV PEP is 
just as important to enable repeat HIV testing. In KwaZulul-
Natal, of  those who returned for follow up who had not 
been eligible for PEP due to delayed presentation >72 hours, 
25% (2/8) became HIV positive, suggesting that this is a high 
risk group16. Undetected seroconversion in both PEP treated 
and non PEP treated groups poses a significant risk both to 
the individual and community16.Thus to provide an effective 
service, recordable follow up is essential. Our service needs 
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to be developed to provide documented follow up to be able 
to monitor the efficacy of  treatment. In addition children 
and guardians need to be educated on the importance of  
compliance and attendance of  follow up appointments.
Should we provide HIV PEP to more CSA 
victims?
It has been argued that the potential benefit of  offering HIV 
PEP to more victims of  CSA outweighs the risks. In particular 
it is felt by some that HIV PEP should still be given if  there 
have been multiple CSA episodes in the last 6 months, and 
the child is HIV negative on testing22. It is not offered in 
our service in these circumstances in view of  the possibility 
of  having already acquired HIV, but being in the window 
period of  seroconversion. However others argue that this is 
not necessarily the case and in some of  these cases providing 
HIV PEP may prevent the acquisition of  HIV from the most 
recent assault22. Guardians would need to be fully counselled 
on the possibility of  becoming seropositive if  they are in fact 
in the window period of  seroconversion. In our group 25% 
(54/217) had suffered multiple defilement episodes, thus 
excluding them from treatment with HIV PEP.
In addition, in our service HIV PEP is withheld if  there is 
a normal physical examination. This is because although it 
is known that sexual penetration can occur without causing 
physical signs on examination, if  there are no signs of  trauma 
the risk of  HIV acquisition is much lower. However others 
argue the need to consider HIV PEP in these cases in countries 
with high HIV prevalence22. Ellis et al1 have argued that in 
this situation the risks of  treatment outweigh the benefits. 
However in studies from Kenya17 and South Africa16,25 both 
with a similar adult HIV prevalence to Malawi10, children 
with a normal physical examination were not excluded. The 
American Academy of  Pediatrics advise considering PEP in 
cases without trauma8, a country with a much lower incidence 
of  HIV prevalence10. Thus providing HIV PEP to otherwise 
eligible children with normal examination findings should be 
re-considered in our setting. Some guidelines recommend 
the consideration of  HIV PEP after 72 hours in high risk 
circumstances5. However animal models of  PEP have shown 
no benefit of  PEP if  begun after 72 hours of  exposure23.
It is firmly established that if  the family refuse testing they 
should not be offered HIV PEP due to the risk that they 
may already be HIV positive and HIV PEP could lead to the 
development of  drug resistance in that individual5.
In summary the benefit needs to outweigh the risks of  
treatment, which are side effects of  medication, potential 
development of  drug resistance and cost. The decision to 
start HIV PEP needs to occur on a patient to patient basis.
Recommendations
Provision of  HIV PEP provides an opportunity to 
improve services for victims of  CSA
Provision of  HIV PEP for CSA not only prevents some 
children from acquiring HIV from CSA, but attracts more 
children and guardians to the service, as well as inter-
professional referral to the service. Thus they can be offered 
further medical and non-medical services in addition to 
HIV PEP. Other medical treatments include antibiotics to 
prevent and/or treat other STIs, repair of  gross injuries and 
tetanus toxoid if  indicated. Non-medical services include 
the provision of  social and psychological services. Currently 
there are no psychological services available to victims 
of  CSA in QECH but this is an area which would greatly 
benefit children and could be developed within the context 
of  our service. The best model for the victim would be to 
have a one stop multidisciplinary approach including police, 
forensic, social, psychological and legal support services. One 
successful model shown in the Refentse intervention study, 
in a rural South African hospital, is a nurse driven model of  
comprehensive post rape care25.
As stated previously the next essential development of  our 
service is adequate recordable follow up. This would best be 
done at the same point of  contact of  the initial presenting 
visit. Standardised forms should be completed to enable data 
collection of  patients followed up.
The next stage would be to expand the service beyond the 
tertiary hospital to district hospitals. This could only be done 
after a programme of  training of  a nominated paediatric 
clinician from each district hospitals, and with the use of  a 
national standardised clinical assessment form. If  the training 
was fully comprehensive this would allow the clinician to 
carry out assessment of  CSA cases in their district hospital 
with HIV PEP provision. This would enable a greater 
coverage of  HIV PEP to more eligible victims of  CSA, in a 
more timely manner.
References
Ellis JC, Ahmad S, Molyneux EM. Introduction of  HIV post-1. 
exposure prophylaxis for sexually abused children in Malawi. Arch 
Dis Child 2005;90:1297-1299.
Merchant RC, Keshavarz R. Human Immunodeficiency Virus 2. 
post exposure prophylaxis for adolescents and children. Pediatrics 
2001;108(2):e38.
Volmink J, Siegfried NL, van der Merwe L, Brocklehurst P. 3. 
Antiretrovirals for reducing the risk of  mother-to-child transmission 
of  HIV infection. Cochrane Database Syst Rev 2007:1:CD003510.
Young TN, Arens EJ, Kennedy GE, Laurie JW, Rutherford G. 4. 
Antiretroviral post-exposure prophylaxis (PEP) for occupational 
HIV exposure. Cochrane Database Syst Rev 2007;1:CD002835
Fisher M, Benn P, Evans B, Pozniak A, Hawkins D et al. UK Guideline 5. 
for use of  PEP for HIV following sexual exposure. International 
Journal of  STD and AIDS 2006;17:81-92.
Tudor-Williams G. Post-exposure prophylaxis Guidelines for 6. 
children exposed to blood borne viruses. 2007. www.CHIVA.org.uk/
protocols/pep.html.
Smith DK, Grohskopf  LA, Black RJ, Auerback JD, Greenberg AE 7. 
et al. Antiretroviral postexposure prophylaxis after sexual, injection-
drug use, or other non-occupational exposure to HIV in the United 
States. Centers for Disease Control and Prevention. MMWR 
Recommendations and Reports 2005;54(RR02):1-20. http://www.
cdc.gov/mmwr/preview/mmwrhtml/rr5402a1.htm 
Havens PL et al. Postexposure prophylaxis in Children and 8. 
Adolescents for Nonoccupational exposure to HIV. Pediatrics 
2003;111:1475-1489.
Kim JC, Martin LJ, Denny L. Rape and HIV post-exposure 9. 
prophylaxis: addressing the dual epidemics in South Africa. Reprod 
Health Matters 2003;11(22):101-112.
Unicef. Statistics: Malawi. 2005. http://www.unicef.org/10. 
infobycountry/malawi_statistics.html.
Gutman LT, Herman-Giddens ME, McKinney RE Jr. Pediatric 11. 
acquired immunodeficiency syndrome. Barriers to recognising the 
role of  child sexual abuse. Am J Dis Child 1993;147:775-780.
Robson J. Medical Assessment for Defilement. Appendix 1 for Ellis 12. 
JC, Ahmad S, Molyneux EM. Introduction of  HIV post-exposure 
Child abuse cases at QECH following HIV PEP 58
MMJ 21(2) 2009 www.mmj.medcol.mw
prophylaxis for sexually abused children in Malawi. Arch Dis Child 
2005;90:1297-1299. See www.archdischild.com/supplemental.
Ellis JC. Guidelines for Post- Exposure Prophylaxis after Sexual 13. 
Abuse. Appendix 2 for Ellis JC, Ahmad S, Molyneux EM. Introduction 
of  HIV post-exposure prophylaxis for sexually abused children in 
Malawi. Arch Dis Child 2005;90:1297-1299. See www.archdischild.
com/supplemental.
Collings SJ, Wiles WA. Child rape in KwaZulu-Natal, South Africa: 14. 
An analysis of  substantiated cases. Acta Criminologica 2004;17(3):48-
54.
Jones LM, Finkelhor D. Putting together evidence on declining trends 15. 
in sexual abuse: a complex puzzle. Child Abuse Negl 2003;27(2):133-
135.
Collings SJ, Bugwandeen SR, Wiles WA. HIV post-exposure 16. 
prophylaxis for child rape survivors in Kwazulu-Natal, South Africa: 
Who qualifies and who complies? Child Abuse Negl 2008;32(4):477-
83.
Speight CG, Klufio A, Kilonzo SN, Mbugua C, Kuria E, Bunn 17. 
JE, Taegtmeyer M. Piloting post-exposure prophylaxis in Kenya 
raises specific concerns for the management of  childhood rape. 
Transactions of  the Royal Society of  Tropical Medicine and Hygiene 
2006;100:14-18.
Johnson CF. Child sexual Abuse. Lancet 2004;364:462-70.18. 
Boyles T, Freedman A. Post- exposure prophylaxis. Medicine 19. 
2005;33(6):32-33.
Prins JM. HIV post-exposure prophylaxis after occupational and non-20. 
occupational exposure. Gynaecology, Obstetrics, and Reproductive 
Medicine in Daily Practice 2005;1279:105-108.
Haworth A. Problems in establishing post-exposure prophylaxis for 21. 
HIV in sexually abused children in Zambia. In Paper presented at the 
16th ISPCAN International Congress on Child Abuse and Neglect 
2006.
Muula AS. HIV post-exposure prophylaxis for sexually abused 22. 
children in Malawi. Arch Dis Child eLetters for Ellis et al. 
2005;90(12):1297-1299.
Martin LN, Murphey-Corb M, Soike KF, Davison-Fairburn B, Baskin 23. 
GB. Effects of  initiation of  3’-azido, 3’-deoxythymidine (zidovudine) 
treatment at different times after infection of  rhesus monkeys with 
simian immunodeficiency virus. J Infec Dis 1993;168:825-835.
Adams JA, Kaplan RA, Starling SP, Mehta MH, Finkel MA, Botash 24. 
AS, Kellogg ND, Shapiro RA. Guidelines for medical care of  children 
who may have been sexually abused. J Pediatr Adolesc Gynaecol 
2007;20:163-172.
Kim J, Askew I, Muvhango L, Dwane N, Abramsky T, Jan S, Ntlemo 25. 
E, Chege J, Watts C. Comprehensive care and HIV prophylaxis after 
sexual assault in rural South Africa: the Refentse intervention study. 
BMJ 2009;338:b515.
Ipas an international organization that promotes reproductive 
health for women organized a three-day workshop from 30th 
March to 1st April on how the media can effectively report 
on safe abortion. According to statistics presented by the 
vice president for Ipas in Africa, Ambassador Dr. Brookman 
Amissah,  abortions accounts for 1 in 8 maternal deaths 
globally and that 13% of  these are from unsafe abortions. 
She cited that 




silence are a 
major cause of  
unsafe abortions 
particularly in 




p r o f e s s i on a l s 
and amongst 
women in the 
c o m m u n i t i e s 
themselves, that’s 
why we end up 
loosing lives 
which could have 
been saved”.
Making his presentation at the workshop the coordinator for 
Ipas in Malawi who is also a legal practitioner Mr. Godfrey 
Kangaude, mentioned that when reporting about abortion 
law, journalists should not forget that there is also a right 
to life. “The media has a responsibility to help the public to 
reflect to what extent abortion should be legal in the country 
and should help the public discuss what the preservation of  
the mother’s life should mean for Malawians”, he said.
Abortion is illegal in Malawi and according to the penal code 
any person who provides abortion is guilty of  a felony and 
liable to prison for fourteen years. Women who procure 
abortions are guilty and liable to a seven year sentence. While 
reading the legislation, Kangaude revealed that it is safe to 
terminate a pregnancy if  it poses a risk to the life of  the 
woman and that person would not be criminally liable.
The objectives 
of  the workshop 
were to educate 
p a r t i c i p a n t s 
on issues of  
abortion, raise 
awareness on the 
commitments made 
by governments 
at regional and 
international levels 
to reduce unsafe 
abortions,  and to 
report on abortion 




by O media in 
conjunction with 
Ipas and brought 
together officials from the Ministry of  Health, legal 
practitioners, human rights activists and journalists from 
different media houses. .
Ipas is an international organization that works around the 
world to increase women’s ability to exercise their sexual and 
reproductive rights, and to reduce abortion-related deaths 
and injuries.
Ipas trains the media on unsafe abortions
